Show/Hide Menu
Hide/Show Apps
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Open Science Policy
Open Science Policy
Open Access Guideline
Open Access Guideline
Postgraduate Thesis Guideline
Postgraduate Thesis Guideline
Communities & Collections
Communities & Collections
Help
Help
Frequently Asked Questions
Frequently Asked Questions
Guides
Guides
Thesis submission
Thesis submission
MS without thesis term project submission
MS without thesis term project submission
Publication submission with DOI
Publication submission with DOI
Publication submission
Publication submission
Supporting Information
Supporting Information
General Information
General Information
Copyright, Embargo and License
Copyright, Embargo and License
Contact us
Contact us
Targeted photodynamic therapy of pancreatic cancer using fullerene-based nanodrugs
Download
HKI_Thesis.pdf
HAYRİ KERİM İNCE.pdf
Date
2025-9
Author
İnce, Hayri Kerim
Metadata
Show full item record
This work is licensed under a
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
.
Item Usage Stats
4660
views
0
downloads
Cite This
Fullerene-based nanoparticles can regulate reactive oxygen species (ROS) within the tumor microenvironment and induce cancer cell death. However, research on the application of fullerene-based nanoparticles is limited, and the role of fullerene nanocomposites in pancreatic cancer treatment remains unknown. In this study, water-soluble fullerene (C60WS) was synthesized and doped with CeO₂, which generates ROS under hypoxia, to create CeO₂@C60. These nanoparticles were utilized to enhance ROS regulation and selectively target the hypoxic pancreatic cancer microenvironment with the help of Photodynamic Therapy(PDT). Synthesized nanoparticles were characterized by DLS/ELS, UV-Vis spectroscopy, FTIR, and SEM/TEM, and applied to pancreatic cancer cell lines BxPC-3 and SW-1990 in combination with PDT to improve treatment specificity and catalytic activity, for the first time in the literature. Proteomics analysis was conducted to reveal the effects of these nanoparticles on the cells. Cell viability assays revealed IC50 values of 40.4 µM (BxPC-3) and 6.1 µM (SW-1990) for CeO₂@C60, and 13.2 µM (BxPC-3) and 6.5 µM (SW-1990) for C60WS upon PDT. In the dark, C60WS promoted cell growth at this concentration, while CeO₂@C60 shows potent cytotoxicity with an IC50 of 8.9 µM. Proteomics analysis of SW-1990 cells treated with CeO₂@C60 revealed that PDT activates post-translational modification and protein folding pathways. Under light, RNA regulation, transcription, and DNA damage response (DDR) pathways were induced in the control group. In the absence of light and nanoparticles, pathways related to cell migration and reactive nitrogen species (RNS) were activated. These findings provide new insights into the impact of CeO₂@C₆₀ and PDT application on the pancreatic cancer cells.
Subject Keywords
Nanodrugs
,
Fullerene
,
Photodynamic Therapy
,
Pancreatic Cancer
,
Proteomics
URI
https://hdl.handle.net/11511/115685
Collections
Graduate School of Natural and Applied Sciences, Thesis
Citation Formats
IEEE
ACM
APA
CHICAGO
MLA
BibTeX
H. K. İnce, “Targeted photodynamic therapy of pancreatic cancer using fullerene-based nanodrugs,” M.S. - Master of Science, Middle East Technical University, 2025.